Benu BioVentures is launched

Benu BioPharma has established Benu BioVentures, a new biopharmaceutical investment initiative. Funding activities will focus on product candidates with strong animal data and a clear regulatory path that address unmet medical needs. Benu BioVentures is led by Dennis Goldberg, Ph.D., FAHA and Fred Meyer, Ph.D., CFA, both recognized biopharmaceutical serial entrepreneurs.

North AmericaUSBriefs